Literature DB >> 26273963

Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.

Yuyi You1, Vivek K Gupta2, Nitin Chitranshi2, Brittany Reedman2, Alexander Klistorner3, Stuart L Graham3.   

Abstract

The visual evoked potential (VEP) recording is widely used in clinical practice to assess the severity of optic neuritis in its acute phase, and to monitor the disease course in the follow-up period. Changes in the VEP parameters closely correlate with pathological damage in the optic nerve. This protocol provides a detailed description about the rodent model of optic nerve microinjection, in which a partial demyelination lesion is produced in the optic nerve. VEP recording techniques are also discussed. Using skull implanted electrodes, we are able to acquire reproducible intra-session and between-session VEP traces. VEPs can be recorded on individual animals over a period of time to assess the functional changes in the optic nerve longitudinally. The optic nerve demyelination model, in conjunction with the VEP recording protocol, provides a tool to investigate the disease processes associated with demyelination and remyelination, and can potentially be employed to evaluate the effects of new remyelinating drugs or neuroprotective therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26273963      PMCID: PMC4544935          DOI: 10.3791/52934

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

1.  Axonal loss in a rat model of optic neuritis is closely correlated with visual evoked potential amplitudes using electroencephalogram-based scaling.

Authors:  Yuyi You; Alexander Klistorner; Johnson Thie; Vivek K Gupta; Stuart L Graham
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-20       Impact factor: 4.799

Review 2.  Animal models of optic nerve diseases.

Authors:  H Levkovitch-Verbin
Journal:  Eye (Lond)       Date:  2004-11       Impact factor: 3.775

Review 3.  Clinical practice. Optic neuritis.

Authors:  Laura J Balcer
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

4.  Suppression of F-VEP during isoflurane-induced EEG suppression.

Authors:  K Mäkelä; K Hartikainen; M Rorarius; V Jäntti
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1996-05

5.  Body temperature-dependent and independent actions of chlordimeform on visual evoked potentials and axonal transport in optic system of rat.

Authors:  W K Boyes; S Padilla; R S Dyer
Journal:  Neuropharmacology       Date:  1985-08       Impact factor: 5.250

6.  Delayed visual evoked response in optic neuritis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

7.  The effects of lysolecithin on non-myelinated axons in vitro.

Authors:  J Mitchell
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

8.  Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis.

Authors:  Yuyi You; Alexander Klistorner; Johnson Thie; Stuart L Graham
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

9.  Relation of albinism and drugs to the visual evoked potential of the mouse.

Authors:  K R Henry; R W Rhoades
Journal:  J Comp Physiol Psychol       Date:  1978-04

10.  Comparative effects of halothane, isoflurane, sevoflurane and desflurane on the electroencephalogram of the rat.

Authors:  J C Murrell; D Waters; C B Johnson
Journal:  Lab Anim       Date:  2008-04       Impact factor: 2.471

View more
  3 in total

1.  The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION).

Authors:  Yan Guo; Zara Mehrabian; Steven L Bernstein
Journal:  J Vis Exp       Date:  2016-11-20       Impact factor: 1.355

2.  Co-administration of aspirin and adipose-derived stem cell conditioned medium improves the functional recovery of the optic pathway in a lysolecithin-induced demyelination model.

Authors:  Adel Galeshi; Maryam Ghasemi-Kasman; Farideh Feizi; Nahid Davoodian; Leila Zare; Zeinab Abedian
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-17       Impact factor: 2.570

3.  Non-invasive visual evoked potentials under sevoflurane versus ketamine-xylazine in rats.

Authors:  Valerio Castoldi; Raffaele d'Isa; Silvia Marenna; Giancarlo Comi; Letizia Leocani
Journal:  Heliyon       Date:  2021-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.